Skip to content

Exploring How Osteopathic Manipulative Treatment May Affect Spinal Fluid Flow: An MRI Study

Exploring the Impact of Osteopathic Manipulative Treatment on CSF Dynamics: A Mechanistic MRI-Based Investigation

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07629765
Enrollment
30
Registered
2026-06-05
Start date
2026-06-01
Completion date
2027-08-01
Last updated
2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteopathic Manipulative Treatment (OMT) Effects on Cerebrospinal Fluid (CSF) Dynamics

Keywords

Osteopathic Manipulative Treatment, Cerebrospinal Fluid, CSF Dynamics, Brain MRI, Glymphatic System, Aging Brain, Healthy Adults, Manual Therapy

Brief summary

his study aims to investigate whether Osteopathic Manipulative Treatment (OMT) affects cerebrospinal fluid (CSF) flow and glymphatic clearance in the human brain. CSF plays an important role in brain health by supporting nutrient delivery, waste removal, and pressure regulation. Aging and certain neurological conditions are associated with reduced CSF circulation and impaired brain waste clearance. Participants will undergo magnetic resonance imaging (MRI) scans before and after a 30-minute OMT session to evaluate changes in CSF flow dynamics and brain physiology. The study will also examine whether age, cognition, sleep quality, physical function, anxiety, and depression are associated with changes in CSF flow following OMT. The study will enroll healthy adults between 18 and 80 years of age. Data collected from MRI imaging and questionnaires may help improve understanding of the physiological effects of OMT and its potential role in supporting brain health

Detailed description

Cerebrospinal fluid (CSF) is essential for normal central nervous system function, contributing to nutrient transport, waste clearance, and regulation of intracranial pressure. Aging is associated with reductions in CSF production, impaired glymphatic clearance, and altered CSF flow dynamics, which may contribute to cognitive decline and neurodegenerative disease processes. Although osteopathic manipulative treatment (OMT) has been proposed to influence fluid dynamics, circulation, autonomic balance, and tissue mobility, the physiological effects of OMT on CSF flow in humans remain poorly understood. This pilot study will investigate whether OMT alters CSF dynamics and glymphatic-related imaging biomarkers in healthy adults. Thirty healthy participants will be enrolled, including individuals between 18-49 years of age and 50-80 years of age. Participants will complete MRI imaging sessions before and after a standardized 30-minute OMT session. MRI assessments will include structural brain imaging, diffusion tensor imaging (DTI), and phase contrast MRI techniques to evaluate CSF flow, glymphatic-related diffusion metrics, and brain structural characteristics. Participants will also complete questionnaires assessing cognitive function, physical function, sleep quality, anxiety, and depression. The study aims to: 1. Determine whether CSF flow differs with aging. 2. Determine whether OMT modulates CSF flow dynamics. 3. Examine relationships between imaging findings and participant-reported cognitive, physical, sleep, and psychological measures. The results of this study may improve understanding of the mechanistic effects of OMT on brain physiology and provide preliminary data for future studies evaluating OMT-related interventions targeting neurophysiological health.

Interventions

OTHEROsteopathic Manipulative Treatment (OMT)

This intervention consists of a single 30-minute osteopathic manipulative treatment (OMT) session administered by a licensed osteopathic physician trained in neuromusculoskeletal and osteopathic manipulative medicine. Treatment will be individualized based on findings from an osteopathic structural examination assessing somatic dysfunctions involving the head, spine, pelvis, extremities, and myofascial structures. Standardized OMT techniques may include osteopathic cranial manipulative medicine (OCMM), indirect method (IM), articulatory technique (ART), muscle energy technique (MET), facilitated positional release (FPR), tender point high-velocity low-amplitude (TP-HVLA), and myofascial release (MFR). The intervention is performed between pre- and post-treatment MRI sessions to evaluate acute changes in cerebrospinal fluid (CSF) dynamics and glymphatic-related imaging biomarkers.

Sponsors

Edward Via Virginia College of Osteopathic Medicine
Lead SponsorOTHER
Auburn University MRI Research Center
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults between 18 and 80 years of age * Able and willing to provide informed consent * Able to safely undergo MRI procedures * Able to participate in osteopathic manipulative treatment (OMT)

Exclusion criteria

* History of severe traumatic brain injury * Fibromyalgia * Epilepsy * Severe neurodegenerative disorders * Brain tumor or brain metastasis * Stroke or cerebrovascular disease * Hydrocephalus * Brain malformations * Demyelinating disorders * Congenital abnormalities affecting cerebrospinal fluid (CSF) flow * Spinal stenosis * Prior brain surgery * Chiari malformation * Syringomyelia * Other spinal conditions that may disrupt CSF flow * Manual therapy within the previous 2 weeks * Use of medications that affect CSF flow and/or production (including carbonic anhydrase inhibitors, furosemide, thiopental, desflurane, halothane, ketamine, etc.) * Uncontrolled hypertension * Uncontrolled diabetes * MRI contraindications, including implanted metallic/electronic devices or -severe claustrophobia * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in Cerebrospinal Fluid (CSF) Velocity Following OMTImmediately before and immediately after the single OMT session during the study visit.CSF aqueductal peak and average velocity measured using phase contrast MRI before and after osteopathic manipulative treatment (OMT).
Change in Cerebrospinal Fluid (CSF) Flow Volume Dynamics Following OMTImmediately before and immediately after the single OMT session during the study visit.CSF forward and reverse flow volumes, net forward flow, and stroke volume measured using phase contrast MRI before and after osteopathic manipulative treatment (OMT).

Secondary

MeasureTime frameDescription
Changes in the Diffusion Tensor Imaging Analysis along the Perivascular Space (DTI-ALPS) indexImmediately before and immediately after the single OMT session during the study visit.An MRI diffusion tensor imaging-based physiological measure of perivascular water diffusivity, measured before and after OMT. The DTI-ALPS assessment quantifies directional water diffusivity within white matter tracts to evaluate fluid movement along perivascular spaces.
Correlation Between MRI-Derived CSF Flow, Velocity, and DTI-ALPS Metrics and Cognitive Function Outcomes Using the Patient-Reported Outcomes Measurement Information System (PROMIS) Cognitive Function Short Form and PROMIS Cognitive Abilities Short FormQuestionnaires completed during the study visit prior to imaging procedures.Association between changes in cerebrospinal fluid (CSF) flow and velocity metrics measured using magnetic resonance imaging (MRI) and changes in the Diffusion Tensor Imaging Analysis along the Perivascular Space (DTI-ALPS) index measured using diffusion tensor imaging (DTI) (units: quantitative CSF flow parameters, CSF velocity measures, and ALPS index ratio) and participant-reported cognitive function measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Cognitive Function Short Form and PROMIS Cognitive Abilities Short Form (unit: PROMIS T-scores; range typically 0-100, standardized mean = 50, SD = 10; higher scores indicate better cognitive function and cognitive abilities).

Countries

United States

Contacts

CONTACTDaniel Cawley, DC, MS, MSHS
dcawley@vcom.edu706-442-4105
CONTACTAdil Bashir, PhD, MS
azb0117@auburn.edu334-844-1816
PRINCIPAL_INVESTIGATORDaniel Cawley, DC, MS, MSHS

Edward Via College of Osteopathic Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026